These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8171227)

  • 1. Anti-IgE autoantibodies in asthma: a diagnostic artefact or an explanation for non-allergic asthma?
    Stadler BM
    Rev Med Suisse Romande; 1994 Mar; 114(3):199-201. PubMed ID: 8171227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-IgE autoantibody in patients with bronchial asthma.
    Nawata Y; Koike T; Yanagisawa T; Iwamoto I; Itaya T; Yoshida S; Tomioka H
    Clin Exp Immunol; 1984 Nov; 58(2):348-56. PubMed ID: 6388923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
    Owen CE
    Pharmacol Ther; 2007 Jan; 113(1):121-33. PubMed ID: 17000005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the interrelationship between circulating IgG subclass anti-IgE autoantibodies, IgE and soluble CD23 in asthma.
    Shakib F; Boulstridge L; Smith SJ
    Allergol Immunopathol (Madr); 1993; 21(1):20-4. PubMed ID: 7687088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
    D'Amato G
    Eur J Pharmacol; 2006 Mar; 533(1-3):302-7. PubMed ID: 16464445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isotypic analysis of grass pollen-specific antibodies in human plasma. 4. Biological activity of allergen-specific and autoanti-IgE antibody fractions on basophil histamine release.
    Batard T; Weyer A; Laroze A; Ickovic MR; David B; Peltre G; Basuyaux B
    Clin Exp Allergy; 1996 Nov; 26(11):1308-15. PubMed ID: 8955580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-IgE autoantibodies: a possible specific feedback on the cytokine network in allergy?
    Stadler BM
    Eur Cytokine Netw; 1992; 3(5):437-41. PubMed ID: 1477294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases.
    Chang TW; Wu PC; Hsu CL; Hung AF
    Adv Immunol; 2007; 93():63-119. PubMed ID: 17383539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum-IgE-facilitated allergen presentation in atopic disease.
    van der Heijden FL; Joost van Neerven RJ; van Katwijk M; Bos JD; Kapsenberg ML
    J Immunol; 1993 Apr; 150(8 Pt 1):3643-50. PubMed ID: 8468493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
    Halken S
    Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous serum skin test for autoantibodies is associated with airway hyperresponsiveness in patients with asthma.
    Jang AS; Park JS; Lee JH; Park SW; Kim DJ; Park CS
    Respiration; 2007; 74(3):293-6. PubMed ID: 17028420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of cross-reactive immunoglobulin E antibodies: peanut-specific immunoglobulin E sensitizes basophils to tree nut allergens.
    de Leon MP; Drew AC; Glaspole IN; Suphioglu C; Rolland JM; O'Hehir RE
    Clin Exp Allergy; 2005 Aug; 35(8):1056-64. PubMed ID: 16120088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST; Djukanović R; Casale T; Bousquet J
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-immunoglobulin E therapy with omalizumab for asthma.
    Hendeles L; Sorkness CA
    Ann Pharmacother; 2007 Sep; 41(9):1397-410. PubMed ID: 17698897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of antigen specific IgE responses in Japanese asthmatics and non-asthmatics].
    Takahashi D; Hizawa N; Maeda Y; Fukui Y; Nishimura M
    Arerugi; 2004 Oct; 53(10):1071-8. PubMed ID: 15672726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of insect allergen-specific IgE in allergic asthmatic children in Cincinnati, Ohio.
    Lierl MB; Riordan MM; Fischer TJ
    Ann Allergy; 1994 Jan; 72(1):45-50. PubMed ID: 8291749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Early Treatment of the Atopic Child.
    Pediatr Allergy Immunol; 1998 Aug; 9(3):116-24. PubMed ID: 9814724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic asthma: not so different from allergic asthma but driven by superantigens?
    Barnes PJ
    Clin Exp Allergy; 2009 Aug; 39(8):1145-51. PubMed ID: 19538350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific IgE against Alternaria alternata in atopic dermatitis and asthma patients.
    Hedayati MT; Arabzadehmoghadam A; Hajheydari Z
    Eur Rev Med Pharmacol Sci; 2009; 13(3):187-91. PubMed ID: 19673169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of allergic bronchial asthma with omalizumab - an anti-IgE monoclonal antibody.
    D'Amato G
    Expert Opin Biol Ther; 2003 Apr; 3(2):371-6. PubMed ID: 12662149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.